Birchview Capital, LP
Filing Date
Global Rank
#4,926
/ 8,603
▲ 198
· as of Mar 2026
Top Industry
Biotechnology
60.5%
3Y Alpha vs SPY
-7.9%
Period ended 3 months ago
Filed May 15, 2026 · 55d
25 quarters · since Mar 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+32.9%
SPY
+76.5%
Annualised alpha
-10.9%
Max drawdown
−24.1%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
69 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
13.0%
+1.4 pts
Top 5
33.0%
−0.3 pts
Top 10
49.3%
−1.2 pts
HHI
394
Diversified+3
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 85.4% | $122,120,441 |
| Technology | 7.4% | $10,619,352 |
| Energy | 6.0% | $8,584,353 |
| Basic Materials | 0.7% | $1,060,391 |
| Financial Services | 0.4% | $568,600 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
10 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| PACB | Pacific Biosciences Of California, Inc. | +1,000,000 | 1,500,000 | $1,980,000 | |
| NTLA | Intellia Therapeutics, Inc. | +130,000 | 445,400 | $5,710,028 | |
| QURE | uniQure N.V. | +69,908 | 100,697 | $1,646,395 | |
| NVCR | NovoCure Ltd | +50,230 | 202,330 | $2,205,397 | |
| GPCR | Structure Therapeutics Inc. | +10,000 | 100,000 | $4,820,000 | |
| PRTA | Prothena Corp Public Ltd Co | +8,000 | 449,019 | $4,364,464 | |
| BMY | Bristol Myers Squibb Co | +3,426 | 306,268 | $18,575,154 | |
| UTHR | UNITED THERAPEUTICS Corp | +1,500 | 4,500 | $2,668,410 | |
| BCYC | Bicycle Therapeutics PLC | +899 | 463,599 | $2,151,099 | |
| ZNTL | Zentalis Pharmaceuticals, Inc. | +503 | 17,503 | $40,957 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
20 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CMPX | Compass Therapeutics, Inc. | −127,071 | 1,465,867 | $7,754,436 | |
| GOSS | Gossamer Bio, Inc. | −120,000 | 18,176 | $5,979 | |
| ELUT | Elutia Inc. | −97,924 | 165,094 | $173,348 | |
| PHR | Phreesia, Inc. | −96,400 | 14,300 | $119,834 | |
| IMNM | Immunome Inc. | −80,000 | 50,000 | $1,093,500 | |
| SLDB | Solid Biosciences Inc. | −79,975 | 625,980 | $4,507,056 | |
| CSTL | Castle Biosciences Inc | −67,700 | 12,900 | $316,695 | |
| OLMA | Olema Pharmaceuticals, Inc. | −50,000 | 219,000 | $3,265,290 | |
| STOK | Stoke Therapeutics, Inc. | −50,000 | 210,000 | $6,837,600 | |
| PTGX | Protagonist Therapeutics, Inc | −20,000 | 35,000 | $3,689,000 | |
| CORT | Corcept Therapeutics Inc | −20,000 | 47,200 | $1,902,632 | |
| TVTX | Travere Therapeutics, Inc. | −13,800 | 29,200 | $867,532 | |
| DCGO | DocGo Inc. | −10,335 | 39,573 | $24,891 | |
| HROW | Harrow, Inc. | −10,000 | 24,000 | $846,240 | |
| APGE | Apogee Therapeutics, Inc. | −7,000 | 9,000 | $757,530 | |
| LRCX | Lam Research Corp | −4,329 | 36,000 | $7,691,760 | |
| KLAC | Kla Corp | −2,000 | 19,883 | $2,927,592 | |
| LUNG | Pulmonx Corp | −352 | 250,221 | $322,785 | |
| AXSM | Axsome Therapeutics, Inc. | −61 | 6,000 | $1,014,120 | |
| FCX | Freeport-Mcmoran Inc | −6 | 18,040 | $1,060,391 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
16 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| RLMD | Relmada Therapeutics, Inc. | 409,387 | $2,849,333 | |
| OCUL | Ocular Therapeutix, Inc | 320,000 | $2,710,400 | |
| CLDX | Celldex Therapeutics, Inc. | 70,095 | $2,223,413 | |
| CMPS | COMPASS Pathways plc | 375,000 | $2,073,750 | |
| ENGN | enGene Therapeutics Inc. | 250,000 | $1,702,500 | |
| ZBIO | Zenas BioPharma, Inc. | 70,000 | $1,368,500 | |
| BIIB | Biogen Inc. | 5,000 | $916,650 | |
| LPCN | Lipocine Inc. | 111,786 | $893,170 | |
| IDYA | IDEAYA Biosciences, Inc. | 16,860 | $561,775 | |
| RCUS | Arcus Biosciences, Inc. | 25,889 | $559,202 | |
| RGNX | REGENXBIO Inc. | 66,270 | $555,342 | |
| RCKT | Rocket Pharmaceuticals, Inc. | 127,025 | $454,749 | |
| VRDN | Viridian Therapeutics, Inc.\DE | 20,100 | $393,156 | |
| GRCE | Grace Therapeutics, Inc. | 50,000 | $231,500 | |
| KYNB | Kyntra Bio, Inc. | 22,566 | $152,997 | |
| QNRX | Quoin Pharmaceuticals, Ltd. | 20,000 | $132,000 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
9 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| FOLD | AMICUS THERAPEUTICS, INC. | 253,000 | $3,602,720 | |
| MASI | Masimo Corp | 8,280 | $1,076,896 | |
| TXG | 10x Genomics, Inc. | 59,000 | $962,290 | |
| ILMN | Illumina, Inc. | 6,000 | $786,960 | |
| TMCI | Treace Medical Concepts, Inc. | 226,947 | $556,020 | |
| ATEC | Alphatec Holdings, Inc. | 18,058 | $379,940 | |
| LQDA | Liquidia Corp | 10,000 | $344,900 | |
| INBX | Inhibrx Biosciences, Inc. | 3,698 | $292,142 | |
| ALMS | Alumis Inc. | 10,000 | $97,600 | |
| No positions match the current search. | ||||
69 positions ·
$142,953,137 total
· as of Mar 31, 2026
Showing 1–50
of 69 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| BMY |
Bristol Myers Squibb Co
Healthcare
|
Added | 306,268 | $18,575,154 | 12.99% | |
| CMPX |
Compass Therapeutics, Inc.
Healthcare
|
Reduced | 1,465,867 | $7,754,436 | 5.42% | |
| LRCX |
Lam Research Corp
Technology
|
Reduced | 36,000 | $7,691,760 | 5.38% | |
| STOK |
Stoke Therapeutics, Inc.
Healthcare
|
Reduced | 210,000 | $6,837,600 | 4.78% | |
| OVV |
Ovintiv Inc.
Energy
|
Held | 107,500 | $6,381,200 | 4.46% | |
| NTLA |
Intellia Therapeutics, Inc.
Healthcare
|
Added | 445,400 | $5,710,028 | 3.99% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
Added | 100,000 | $4,820,000 | 3.37% | |
| SLDB |
Solid Biosciences Inc.
Healthcare
|
Reduced | 625,980 | $4,507,056 | 3.15% | |
| PRTA |
Prothena Corp Public Ltd Co
Healthcare
|
Added | 449,019 | $4,364,464 | 3.05% | |
| ACAD |
Acadia Pharmaceuticals Inc
Healthcare
|
Held | 171,000 | $3,806,460 | 2.66% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
Reduced | 35,000 | $3,689,000 | 2.58% | |
| NBIX |
Neurocrine Biosciences Inc
Healthcare
|
Held | 27,190 | $3,582,010 | 2.51% | |
| OLMA |
Olema Pharmaceuticals, Inc.
Healthcare
|
Reduced | 219,000 | $3,265,290 | 2.28% | |
| KLAC |
Kla Corp
Technology
|
Reduced | 19,883 | $2,927,592 | 2.05% | |
| RLMD |
Relmada Therapeutics, Inc.
Healthcare
|
NEW | 409,387 | $2,849,333 | 1.99% | |
| OCUL |
Ocular Therapeutix, Inc
Healthcare
|
NEW | 320,000 | $2,710,400 | 1.90% | |
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
Added | 4,500 | $2,668,410 | 1.87% | |
| NKTR |
Nektar Therapeutics
Healthcare
|
Held | 31,000 | $2,230,450 | 1.56% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
NEW | 70,095 | $2,223,413 | 1.56% | |
| NVCR |
NovoCure Ltd
Healthcare
|
Added | 202,330 | $2,205,397 | 1.54% | |
| EQT |
EQT Corp
Energy
|
Held | 34,619 | $2,203,153 | 1.54% | |
| PHAT |
Phathom Pharmaceuticals, Inc.
Healthcare
|
Held | 195,000 | $2,166,450 | 1.52% | |
| BCYC |
Bicycle Therapeutics PLC
Healthcare
|
Added | 463,599 | $2,151,099 | 1.50% | |
| CMPS |
COMPASS Pathways plc
Healthcare
|
NEW | 375,000 | $2,073,750 | 1.45% | |
| PACB |
Pacific Biosciences Of California, Inc.
Healthcare
|
Added | 1,500,000 | $1,980,000 | 1.39% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Held | 30,000 | $1,977,300 | 1.38% | |
| CORT |
Corcept Therapeutics Inc
Healthcare
|
Reduced | 47,200 | $1,902,632 | 1.33% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Held | 44,000 | $1,770,120 | 1.24% | |
| ALKS |
Alkermes plc.
Healthcare
|
Held | 50,000 | $1,768,000 | 1.24% | |
| ENGN |
enGene Therapeutics Inc.
Healthcare
|
NEW | 250,000 | $1,702,500 | 1.19% | |
| QURE |
uniQure N.V.
Healthcare
|
Added | 100,697 | $1,646,395 | 1.15% | |
| ZBIO |
Zenas BioPharma, Inc.
Healthcare
|
NEW | 70,000 | $1,368,500 | 0.96% | |
| FHTX |
Foghorn Therapeutics Inc.
Healthcare
|
Held | 281,730 | $1,346,669 | 0.94% | |
| RARE |
Ultragenyx Pharmaceutical Inc.
Healthcare
|
Held | 62,000 | $1,298,900 | 0.91% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Held | 21,000 | $1,221,150 | 0.85% | |
| KALV |
KalVista Pharmaceuticals, Inc.
Healthcare
|
Held | 57,000 | $1,147,410 | 0.80% | |
| IMNM |
Immunome Inc.
Healthcare
|
Reduced | 50,000 | $1,093,500 | 0.76% | |
| FCX |
Freeport-Mcmoran Inc
Basic Materials
|
Reduced | 18,040 | $1,060,391 | 0.74% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
Reduced | 6,000 | $1,014,120 | 0.71% | |
| BIIB |
Biogen Inc.
Healthcare
|
NEW | 5,000 | $916,650 | 0.64% | |
| LPCN |
Lipocine Inc.
Healthcare
|
NEW | 111,786 | $893,170 | 0.62% | |
| TVTX |
Travere Therapeutics, Inc.
Healthcare
|
Reduced | 29,200 | $867,532 | 0.61% | |
| HROW |
Harrow, Inc.
Healthcare
|
Reduced | 24,000 | $846,240 | 0.59% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
Held | 29,847 | $843,177 | 0.59% | |
| VSTM |
Verastem, Inc.
Healthcare
|
Held | 150,000 | $795,000 | 0.56% | |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
Reduced | 9,000 | $757,530 | 0.53% | |
| HALO |
Halozyme Therapeutics, Inc.
Healthcare
|
Held | 10,100 | $652,763 | 0.46% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Held | 8,688 | $645,170 | 0.45% | |
| APLS |
Apellis Pharmaceuticals, Inc.
Healthcare
|
Held | 14,000 | $563,220 | 0.39% | |
| IDYA |
IDEAYA Biosciences, Inc.
Healthcare
|
NEW | 16,860 | $561,775 | 0.39% |